Connect your AI

NuSkin Enterprises NUS Other liabilities

Other liabilities at other companies

USANA Health SciencesUSNA

-$11.95M-89.6%

Other financials

Income statement

Revenue$320.6M-12.0%

Gross profit$214.5M-13.2%

Operating income$4.0M+141%

Net income$1.8M-98.3%

EPS (diluted)$0.04-98.1%

Balance sheet

Cash & equivalents$198.7M-2.5%

Total debt$303.6M-8.2%

Total equity$794.1M+5.3%

Total assets$1.4B-1.1%

Cash flow

Operating cash flow-$3.9M-1,107%

CapEx$13.7M+1.0%

Free cash flow-$17.6M-33.6%

Valuation

Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is NuSkin Enterprises's other liabilities?: NuSkin Enterprises (NUS) reported other liabilities of -$2.97M in Q1 2026.
How has NuSkin Enterprises's other liabilities changed year-over-year?: NuSkin Enterprises's other liabilities decreased by 59.9% year-over-year, from -$1.86M to -$2.97M.